Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain × Triamcinolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pain 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leiomyoma 1 Keratosis, Actinic 1 Hodgkin Disease 1 Dermatitis, Contact 1 Dendritic Cell Sarcoma, Interdigitating 1 Chalazion 1 Carcinoma, Basal Cell 1 Burkitt Lymphoma 1 Anemia, Refractory, with Excess of Blasts 1 Adenomyosis 1

Interventions

Fentanyl 21 Analgesia 18 Acupuncture Therapy 17 Morphine 16 Zoledronic Acid 13 Oxycodone 12 Acetaminophen 12 Lidocaine 11 Ketamine 11 Therapeutics 10 Radiotherapy 10 Methadone 10 Ibandronic Acid 10 Hydromorphone 10 Bupivacaine 8 nabiximols 7 Surveys and Questionnaires 7 Ropivacaine 7 Early Intervention, Educational 6 Water 5 Tapentadol 5 Psychiatric Rehabilitation 5 Pregabalin 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Analgesics, Opioid 5 Yoga 4 Therapeutic Touch 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡